The National Association of County and City Health Officials (NACCHO) yesterday released its 2024 Forces of Change Survey ...

Cambodia's health ministry today announced another human H5N1 avian flu case of the year, involving a 5-year-old boy from ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.